コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 , to inhibit the hydrolytic activity of acid ceramidase.
2 o produce and purify recombinant, human acid ceramidase.
3 s who lack the degradative enzyme galactosyl ceramidase.
4 S. cerevisiae that also encodes an alkaline ceramidase.
5 fied a rat brain membrane-bound nonlysosomal ceramidase.
6 educed transcriptional up-regulation of acid ceramidase.
7 indicate that the purified enzyme is a novel ceramidase.
8 tly explain its original identification as a ceramidase.
9 s dependent on generation of sphingosine via ceramidase.
10 erized functional null mutants of Drosophila ceramidase.
11 mportant signaling lipid, by the activity of ceramidases.
12 s were completely resistant to inhibitors of ceramidases.
13 e degradation due to increased expression of ceramidases.
14 D-e-C(18:1)-ceramide, a common substrate of ceramidases.
15 nerated from the hydrolysis of ceramides via ceramidases.
16 cordingly called acid, neutral, and alkaline ceramidases.
17 +(o) markedly upregulates the human alkaline ceramidase 1 (haCER1) in HEKs; and its upregulation medi
21 Here we demonstrate that the human alkaline ceramidase 2 (ACER2), a Golgi enzyme, regulates beta1 ma
22 up-regulated the expression of the alkaline ceramidase 2 (ACER2), and the ACER2 up-regulation decrea
24 te that our previously cloned human alkaline ceramidase 3 (ACER3) specifically controls the hydrolysi
29 whether physiological hypoxia increased acid ceramidase (AC) expression; and (f) the effect of the AC
31 ulating ulcerative colitis, the role of acid ceramidase (AC) in intestinal inflammation is yet to be
37 utoproteolytic cleavage of the inactive acid ceramidase (AC) precursor into the active heterodimer ex
39 strate that ceramide-deacylating enzyme acid ceramidase (AC) was preferentially upregulated in irradi
40 yotubes that constitutively overexpress acid ceramidase (AC), an enzyme that catalyzes the lysosomal
41 evealed that desipramine down-regulated acid ceramidase (AC), but not sphingosine kinase, at the prot
43 that the ceramide-metabolizing enzyme, acid ceramidase (AC), is expressed in human cumulus cells and
44 e gene (Asah1) encoding one ceramidase, acid ceramidase (AC), lead to the lysosomal storage disorder
45 A and genomic sequences encoding murine acid ceramidase (AC; E.C. 3.5.1.23) have been isolated and ch
46 Herein we report the mechanism of human acid ceramidase (AC; N-acylsphingosine deacylase) cleavage an
51 t mutations in the gene (Asah1) encoding one ceramidase, acid ceramidase (AC), lead to the lysosomal
52 rotective action and investigate the role of ceramidase activation in adiponectin anti-inflammatory s
53 2C11 by IL-1beta in rat hepatocytes and that ceramidase activation provides a "switch" that determine
55 IL-1beta increases both acid and neutral ceramidase activities, which appear to be regulated by t
57 g the pcDNA3.1/His-ceramidase construct, and ceramidase activity (at pH 9.5) increased by 50- and 12-
58 void of any ceramidase activity restored the ceramidase activity and caused an increase in the hydrol
59 have demonstrated that BWA does not exhibit ceramidase activity and that bwa null mutants display no
60 ected, providing an accurate measure of acid ceramidase activity as low as 0.1 pmol/mg protein/h.
61 show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, A
63 s revealed rapid internalization of the acid ceramidase activity from the hamster cell media but not
65 dy reports a new assay method to detect acid ceramidase activity in vitro using Bodipy or lissamine r
70 ctively, these results suggest that alkaline ceramidase activity is important for the generation of S
73 ocytes have alkaline but not acid or neutral ceramidase activity on D-e-C(18:1)-ceramide, a common su
74 that the yeast gene YPC1 encodes an alkaline ceramidase activity responsible for the breakdown of dih
75 ssion in a yeast mutant strain devoid of any ceramidase activity restored the ceramidase activity and
77 m by mediating, at least in part, a cellular ceramidase activity that catalyses the hydrolysis of cer
79 of aPHC in mammalian cells elevated in vitro ceramidase activity toward N-4-nitrobenz-2-oxa-1,3-diazo
81 , perinuclear distribution, although no acid ceramidase activity was detected in the transfected cell
83 ls (Deltaypc1Deltaydc1) that lack endogenous ceramidase activity, and microsomes from ACER2-expressio
84 nd highly sensitive method to determine acid ceramidase activity, and that it could be useful whereve
85 receptors mediate their effects via a novel ceramidase activity, generating sphingoid base as a seco
87 mouse kidney extracts as the source of acid ceramidase activity, this new method was compared with a
94 e is remarkably homologous to human glucosyl ceramidase, an enzyme involved in the ceramide signallin
97 vide important new information on human acid ceramidase and further document its central role in sphi
98 ramide synthase, sphingomyelin synthase, and ceramidase and small interfering RNA knockdown of human
99 ALDI-IMS in combination with novel on-tissue ceramidase and sphingomyelinase enzyme digestions makes
101 mide preceded transient activation of acidic ceramidase and subsequent production of sphingosine, fol
102 effect on transcriptional activation of acid ceramidase and that CerS2 slightly but significantly dec
103 These studies provide new insights into acid ceramidase and the related lipid hydrolase, acid sphingo
104 r determining the activity and inhibition of ceramidases and may be adapted for quantifying sphingomy
108 f a cDNA encoding for a novel human alkaline ceramidase (aPHC) that hydrolyzes phytoceramide selectiv
112 alysis of sequences homologous to human acid ceramidase (ASAH) revealed a 1233-bp cDNA (previously de
115 Moreover, suppression of expression of acid ceramidase (ASAH1), an enzyme that produces SPH, increas
116 dependence is demonstrated both by in vitro ceramidase assays and in intact hepatocytes using a fluo
117 eport detailed characterization of this acid ceramidase-associated "reverse activity" and provide evi
120 these discrepancies are due to activation of ceramidase by the low concentrations of IL-1beta ( appro
122 rane bSMase-induced ceramide using bacterial ceramidase caused ERM hyperphosphorylation and formation
124 EK 293 and MCF7 cells using the pcDNA3.1/His-ceramidase construct, and ceramidase activity (at pH 9.5
125 neration in arrestin mutant flies expressing ceramidase correlated with a decrease in ceramide levels
126 sembly of ceramide channels, as initiated by ceramidase, could be accelerated by the direct interacti
129 autosomal recessive disorder caused by acid ceramidase deficiency that usually presents as early-ons
130 limits of detection for sphingosine-NDA and ceramidase-derived sphingosine-NDA were 9.6 and 12.3 fmo
136 Therefore, the phenotypic consequence of ceramidase expression in photoreceptors is caused by fac
139 ha) and 40 (beta)-kDa subunits as human acid ceramidase from natural sources, had an acidic pH optimu
140 We have previously purified a membrane-bound ceramidase from rat brain and recently cloned the human
143 ts showed that the green fluorescent protein-ceramidase fusion protein presented a mitochondrial loca
146 hat: (i) the structure of the murine neutral ceramidase gene is virtually identical to that of the hu
147 y functions to repress the expression of the ceramidase genes YDC1 and YPC1, thereby revealing, for t
149 inhibitor D-e-MAPP, suggesting that alkaline ceramidases have a role in the generation of SPH and S1P
154 n mediate transcriptional activation of acid ceramidase in a JNK-dependent manner that is independent
159 ll-nonautonomous function, overexpression of ceramidase in tissues distant from photoreceptors suppre
160 e-MAPP functions as an inhibitor of alkaline ceramidase in vitro and in cells resulting in elevation
161 These studies point to an important role for ceramidases in the regulation of endogenous levels of ce
163 tivation/C20:4 generation; (2) C20:4-induced ceramidase inhibition, coupled with SMase stimulation, m
164 S1P increases were inhibited by the alkaline ceramidase inhibitor D-e-MAPP, suggesting that alkaline
165 strongly by the incubation of cells with the ceramidase inhibitor D-erythro-2-tetradecanoylamino-1-ph
166 TNF-alpha and IL-1beta cross-signaling, the ceramidase inhibitor N-oleoyl ethanolamine (1 microM) or
168 -2-(N-myristoylamino)-1-phenyl-1-propanol, a ceramidase inhibitor, and TNFalpha, a homologue of adipo
170 tment of nude mice with B13, the most potent ceramidase inhibitor, completely prevented tumor growth
172 ults indicate that the Asah2-encoded neutral ceramidase is a key enzyme for the catabolism of dietary
173 These results demonstrate that this novel ceramidase is a mitochondrial enzyme, and they suggest t
175 Furthermore, our results show that secreted ceramidase is internalized and localizes to endosomes.
176 ngosine, a product of ceramide hydrolysis by ceramidase, is capable of destabilizing ceramide channel
177 show that, although BWA is unlikely to be a ceramidase, it is a regulator of sphingolipid flux in Dr
179 renamed human ASAHL since it is a human acid ceramidase-like sequence), chromosomal location, primer
180 d characterization of a novel mouse alkaline ceramidase (maCER1) with a highly restricted substrate s
182 he brush border, suggesting that the neutral ceramidase may be involved in a pathway for the digestio
186 solated and characterized the murine neutral ceramidase (N-CDase) gene, mapped its chromosomal locati
187 analogs (C2- or C6-ceramide) or inhibitor of ceramidase (N-oleoyl ethanolamine) led to a time- and do
188 sphingosine production using an inhibitor of ceramidase, n-oleoylethanolamine, completely abrogated t
189 Both acidic ceramidase (aCDase) and neutral ceramidase (nCDase) activities declined after L- and H-U
191 itochondria due to the activation of neutral ceramidase (NCDase) and the reduced activity of sphingos
194 ated analogues of ceramide and inhibitors of ceramidases offer a promising therapeutic strategy with
195 olino-1-propanol (PDMP), which inhibits acid ceramidase or glucosylceramide synthase and then increas
196 an myocardial function; and c) inhibition of ceramidase or nitric oxide synthase attenuates myocardia
198 olic conversion, with specific inhibitors of ceramidase or sphingosine kinase, attenuated the expecte
200 I tract raising the possibility that neutral ceramidase plays a detoxifying role against inadvertent
202 veolar macrophages, because there was little ceramidase protein or activity (or sphingosine) in monoc
203 uced inflammatory response via Cav1-mediated ceramidase recruitment and activation in an AdipoR1-depe
204 Targeted expression of Drosophila neutral ceramidase rescued retinal degeneration in arrestin and
205 h N-oleoylethanolamine (OE), an inhibitor of ceramidase, results in resistance to DNA damage-induced
206 that highly purified liver mitochondria have ceramidase, reverse ceramidase, and thioesterase activit
207 Sphingosine is generated by the action of ceramidase(s) on ceramide, and alveolar macrophages have
209 uced apoptosis in various organs may involve ceramidases that facilitate the degradation of ceramide.
210 hytoceramidase, the first mammalian alkaline ceramidase to be identified as being specific for the hy
211 hod utilizes purified human recombinant acid ceramidase to completely hydrolyze ceramide to sphingosi
216 ed sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic
219 interfering RNA knockdown of human alkaline ceramidase, which all increase endogenous ceramide level
220 ces cerevisiae gene YPC1 encodes an alkaline ceramidase with a dual activity, catalyzing both hydroly
221 data suggest that maCER1 is a novel alkaline ceramidase with a stringent substrate specificity and th
222 ore the physiological functions of a neutral ceramidase with diverse cellular locations, we disrupted
223 ly hydrolyzes phytoceramide, whereas the new ceramidase YDC1p hydrolyzes dihydroceramide preferential
225 d on sequence homology to the yeast alkaline ceramidases YPC1p, we report the identification and clon
226 d 32% identity to the Saccharomyces alkaline ceramidases (YPC1p and YDC1p) and the human alkaline phy
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。